What sector does Chong Kun Dang Pharmaceutical Corp. belong to?

Chong Kun Dang Pharmaceutical Corp. operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 185750?

As of the latest available quote, 185750 traded at ₩66,800.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 185750?

Chong Kun Dang Pharmaceutical Corp. has a price-to-earnings (P/E) ratio of about 11.36. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 185750?

The market capitalisation of Chong Kun Dang Pharmaceutical Corp. is approximately ₩883.85B.

Is Chong Kun Dang Pharmaceutical Corp. profitable?

For its latest reported financial year, Chong Kun Dang Pharmaceutical Corp. recorded a net profit margin of about 4.60%.

Does 185750 pay a dividend?

Chong Kun Dang Pharmaceutical Corp. currently has a dividend yield of about 0.60%.

What is the return on equity (ROE) of 185750?

Chong Kun Dang Pharmaceutical Corp. has a return on equity (ROE) of about 7.72%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 185750?

Over the past 52 weeks, 185750 has traded between a low of ₩63,000.00 and a high of ₩98,100.00.

Chong Kun Dang Pharmaceutical Corp.

185750 KRX Pharmaceuticals Pharmaceuticals

KOSPI

₩66,800.00

-1.76%

Delayed · cached 15 min

Fair value analysis

185750

Chong Kun Dang Pharmaceutical Corp.

₩66,800.00

Close used for this calculation

₩92,552.59Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

47/100

Profitability11/25

Returns8/25

Balance Sheet10/25

Efficiency18/25

Growth11/25

Average

Quality radar

Consensus fair value

₩92,552.59

Below FV

▲ +38.6% against the close used

Model range ₩32,640.91 – ₩170,499.57

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩32,640.91Fair value₩92,552.59Bull₩170,499.57

FairClose

52-week traded range

52W low ₩64,100.0052W high ₩97,700.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Chong Kun Dang Pharmaceutical Corp. closed at ₩66,800.00, 27.8% below the consensus fair value of ₩92,552.59 drawn from 9 valuation models.

Financial DNA score 47/100 — Average. P/E of 11.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩101,838.93

+52.5%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=6.6%, r=10%, tg=3%, n=10yr

Graham Number

₩100,230.68

+50.0%

√(22.5 × EPS × BVPS)

EPS=5882, BVPS=75909.09

Graham Formula

₩170,499.57

+155.2%

EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate

g=6.6%, FD=3.3%

P/E Fair Value

₩117,640.00

+76.1%

EPS × 20x (sector P/E)

EPS=5882, Sector P/E=20x

Peter Lynch (PEG)

₩38,938.84

-41.7%

EPS × Growth% (PEG = 1 is fair)

EPS=5882, g=6.6%

EV/EBITDA

₩53,987.58

-19.2%

(EBITDA × 13.3x − Net Debt) ÷ Shares

EBITDA=80.57B

Book Value (P/B)

₩32,640.91

-51.1%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=75909.09, ROE=7.7%, g=6%, r=10%

Reverse DCF

₩66,800.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -0.5% | Historical: 6.6%

Margin of Safety

₩91,914.22

+37.6%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=122552.3, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer